The study reveals that Nrf2 ablation in a mouse model of HCC disrupts multiple metabolic pathways, reducing acetyl-CoA generation and suppressing histone acetylation in tumors but not in normal tissue. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.